Phytopreparations based on cimicifuga root extract for relieving menopausal symptoms
- Authors: Mubarakshina O.A.1, Somova M.N.1, Batishcheva G.A.1, Mubarakshin E.A.2
-
Affiliations:
- N.N. Burdenko Voronezh State Medical University
- "RZhD-Meditsina" Clinical Hospital
- Issue: No 9 (2020)
- Pages: 199-206
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/329647
- DOI: https://doi.org/10.18565/aig.2020.9.199-206
- ID: 329647
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Olga A. Mubarakshina
N.N. Burdenko Voronezh State Medical University
Email: mubarakshina@mail.ru
MD, PhD, Department of Clinical Pharmacology
Marina N. Somova
N.N. Burdenko Voronezh State Medical University
Email: somova_marina@inbox.ru
PhD, assistant professor of clinical pharmacology
Galina A. Batishcheva
N.N. Burdenko Voronezh State Medical University
Email: bat13@mail.ru
MD, Professor, Head of the Department of Clinical Pharmacology
Eduard A. Mubarakshin
"RZhD-Meditsina" Clinical Hospital
Email: edwardmub@mail.ru
physician of gynecological department
References
- Schoenaker D.A., Jackson C.A., Rowlands J.V., Mishra G.D. Socioeconomic position, life-style factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int. J. Epidemiol. 2014; 43(5): 1542-62. https://dx. doi.org/10.1093/ije/dyu094.
- Сметник В.П., Сухих Г.Т., Андреева Е.Н., Балан В.Е., Гависова А.А., Григорян О.Р., Ермакова Е.И., Зайдиева Я.З., Ильина Л.М., Касян В.М., Марченко Л.А., Подзолкова Н.М., Роговская С.И., Сметник А.А., Чернуха Г.Е., Юренева С.В. Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста. Климактерий. 2014; 4: 36с.
- Faubion S.S., Kuhle C.L., Shuster L.T., Rocca W.A. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015; 18(4): 483-91. https://dx. doi.org/10.3109/1 3697137.2015.1020484.
- Biglia N., Cagnacci A., Gambacciani M., Lello S., Maffei S., Nappi R.E. et al. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017; 20(4): 306-12. https://dx. doi. org/ 10.1080/13697137.2017.1315089.
- De Villiers T.J., Gass M.L., Haines C.J., Hall J.E., Lobo R.A., Pierroz D.D. et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013; 16(2): 203-4. https://dx. doi.org/10.3109/13697137.2013.771520.
- Hill D.A., Crider M., Hill S.R. Hormonal therapy and other treatments for symptoms in menopause. Am. Fam. Physician. 2016; 94(11): 884-9.
- The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017; 24(7): 728-53. https://dx. doi.org/10.1097/ GME.0000000000000921.
- Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3): 321-33. https://dx. doi.org/ 10.1001/jama.288.3.321.
- Юренева С.В., Ермакова Е.И. Оценка эффективности альтернативных методов лечения менопаузальных симптомов у женщин в постменопаузе. Гинекология. 2017; 19(1): 21-6.
- Балан В.Е., Зайдиева Я.З. Возможности коррекции климактерических расстройств негормональными средствами. Лечащий врач. 2000; 5-6: 24-6.
- Кузнецова И.В. Фитоэстрогены в лечении климактерических расстройств. Гинекология. 2012; 14(6): 20-3.
- Радзинский В.Е., ред. Лекарственные растения в акушерстве и гинекологии. М.: Эксмо; 2016. 320с.
- Franco O.H., Chowdhury R. et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA. 2016; 315(23): 255463. https://dx. doi.org/10.1001/jama.2016.8012.
- Gorman G.S., Coward L., Darby A. et al. Effects of herbal supplements on the bioactivation of chemotherapeutic agents. J. Pharm. Pharmacol. 2013; 65(7): 1014-25. https://dx. doi.org/10.1111/jphp.12055.
- Прилепская В.Н. Климактерический синдром: инновации в менопаузальной терапии. РМЖ. 2017; 2: 105-8.
- Прилепская В.Н., Богатова И.К., Радзинский В.Е. Новое в профилактике и терапии климактерического синдрома. Гинекология. 2016; 18(1): 7-12.
- Maki P.M., Dumas J. Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin. Reprod. Med. 2009; 27(3): 250-9. https://dx. doi.org/10.1055/s-0029-1216278.
- Drogos L., Rubin L.H., Geller S.E., Banuvar S., Shulman L.P., Maki P.M. Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms. Menopause. 2013; 20(12): 1236-42. https://dx. doi.org/10.1097/ GME.0b013e318291f5a6.
- Van Driel C.M.G., Stuursma A.S., Schroevers M.J., Mourits M.J., de Bock G.H. Mindfulness, cognitive behavioural and behaviour-based therapy for natural and treatment-induced menopausal symptoms: a systematic review and meta-analysis. BJOG. 2019; 126(3): 330-9. https://dx.doi.org/10.1111/1471-0528.15153.
- Lauritsen C.G., Chua A.L., Nahas S.J. Current treatment options: Headache related to menopause - diagnosis and management. Curr. Treat. Options Neurol. 2018; 20(4): 7. https://dx. doi.org/10.1007/s11940-018-0492-7.
- Avis N.E., Crawford S.L., Greendale G. et al. Duration of menopausal vasomotor symptoms over the menopause transition (Study of Women's Health Across the Nation). JAMA Intern. Med. 2015; 175(4): 531-9. https://dx. doi.org/ 10.1001/ jamainternmed.2014.8063.
- Sarri G., Pedder H., Dias S. et al. Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause. BJOG. 2017; 124(10): 1514-23. https://dx. doi.org/10.1111/1471-0528.14619.
- Шапошник О.Д. Климакс и сердечно-сосудистые заболевания: Учебное пособие для врачей. Челябинск: УГМАДО; 2005. 75 с.
- Thurston R.C., Sutton-Tyrrell K., Everson-Rose S.A., Hess R., Powell L.H., Matthews K.A. Hot flashes and carotid intima media thickness among midlife women. Menopause. 2011; 18(4): 352-8. https://dx. doi.org/10.1097/ gme.0b013e3181fa27fd.
- Chester R.C., Kling J.M., Manson J.E. What the Woman’s Health Initiative hastaughtus about menopausal hormone therapy. Clin. Cardiol. 2018; 41(2): 247-52. https://dx. doi.org/10.1002/clc.22891.
- Biglia N., Cagnacci A., Gambacciani M. et al. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017; 20(4): 306-12. https://dx. doi.org/10.1080/13697 137.2017.1315089.
- Юренева С.В., Эбзиева З.Х. Роль гипоталамических (триггеров) нейропептидов в генезе приливов жара. Перспективы новых терапевтических подходов к лечению вазомоторных климактерических симптомов. Акушерство и гинекология. 2017; 8: 105-10.
- ACOG Practice Bulletin No. 141: Management of menopausal symptoms. Obstet. Gynecol. 2014; 123(1): 202-16. https://dx. doi.org/ 10.1097/01. AOG.0000441353.20693.78.
- Schulte-Michels J., Wolf A., Aatz S. et al. а-Hederin inhibits G. protein-coupled receptor kinase 2-mediated phosphorylation of в 2-adrenergic receptors. Phytomedicine. 2016; 23(1): 52-7. https://dx. doi.org/10.1016/j. phymed.2015.12.001.
- Wahab F., Shahab M., Behr R. The involvement of gonadotropin inhibitory hormone and kisspeptin in the metabolic regulation of reproduction. J. Endocrinol. 2015; 225(2): R49-66. https://dx. doi.org/10.1530/JOE-14-0688.
- Tsutsui K., Bentley G.E., Ubuka T., Saigoh E., Yin H., Osugi T. The general and comparative biology of gonadotropin-inhibitory hormone (GnIH). Gen. Comp. Endocrinol. 2007; 153(1-3): 365-70. https://dx.doi.org/ 10.1016/j. ygcen.2006.10.005.
- Сметник В.П., Ильина Л.М., ред. Ведение женщин в пери- и постменопаузе: практические рекомендации. Ярославль: Литера; 2010. 221с.
- Ohmichi M., Tasaka K., Kurachi H., Murata Y. Molecular mechanism of action of selective estrogen receptor modulator in target tissues. Endocr. J. 2005; 52(2): 161-7. https://dx. doi.org/10.1507/endocrj.52.161.
- Ильина Т.А. Большая иллюстрированная энциклопедия лекарственных растений. М.: Эксмо; 2008. 304c.
- Wuttke W., Jarry H., Heiden I., Seidlova-Wuttke D. Effects of Cimicifuga racemosa on estrogen-dependent tissues. Maturitas. 2000; 35(Suppl.1): S34.
- Вуттке В., Горков К., Сайдлова, Вуттке Д. Влияние цимицифуги (Cimicifuga racemosa) на метаболизм в костной ткани, состояние слизистой оболочки влагалища и различные параметры анализа крови у женщин в постменопаузе: двойное слепое плацебо-контролируемое и контролируемое конъюгированными эстрогенами исследование. Русский медицинский журнал. 2008; 16(20): 3-11.
- Beer A.-M., Neff A. Differentiated evaluation of extract-specific evidence on Cimicifuga racemosa's efficacy and safety for climacteric complaints. Evid. Based Complement. Alternat. Med. 2013; 2013: 860602. https://dx. doi.org/ 10.1155/2013/860602.2013.
- Рауш К., Брюкер К., Горков К., Вуттке В. Первые доказательства безопасности для эндометрия экстракта клопогона кистевидного (Actaea и Cimicifuga racemosa). Русский медицинский журнал. 2008; 16(9): 1-8.
- Коломойцева Т.Н., Орлов О.А., Козлова Г.А. Опыт использования препарата из экстракта цимицифуги (Климадинон) в комплексной реабилитации больных раком шейки матки. Опухоли женской репродуктивной системы. 2008; 3: 57-61.
- Hill C.A., Harris R.C., Kim H.J., Harris B.D., Sale C., Boobis L.H. et al. Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids. 2007; 32(2): 225-33. https:// dx. doi.org/ 10.1007/s00726-006-0364-4.
Supplementary files
![](/img/style/loading.gif)